BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33107777)

  • 1. Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy.
    Fu D; Yu JY; Connell AR; Hookham MB; McLeese RH; Lyons TJ
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):754-764. PubMed ID: 33107777
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.
    Villarroel M; Garcia-Ramírez M; Corraliza L; Hernández C; Simó R
    Diabetologia; 2011 Jun; 54(6):1543-53. PubMed ID: 21369818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
    Garcia-Ramírez M; Hernández C; Palomer X; Vázquez-Carrera M; Simó R
    Acta Diabetol; 2016 Feb; 53(1):109-18. PubMed ID: 25936740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorin Prevents Retinal Pigment Epithelial Barrier Breakdown Under Diabetic Conditions by Suppressing p38 MAPK Activation.
    Wang S; Du S; Wu Q; Hu J; Li T
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):2971-9. PubMed ID: 25829413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.
    Trudeau K; Roy S; Guo W; Hernández C; Villarroel M; Simó R; Roy S
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6348-54. PubMed ID: 21715349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions.
    Miranda S; González-Rodríguez Á; García-Ramírez M; Revuelta-Cervantes J; Hernández C; Simó R; Valverde ÁM
    J Cell Physiol; 2012 Jun; 227(6):2352-62. PubMed ID: 21826649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
    Xu HZ; Le YZ
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
    Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
    Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium Tanshinone IIA Silate Alleviates High Glucose Induced Barrier Impairment of Human Retinal Pigment Epithelium through the Reduction of NF-κB Activation via the AMPK/p300 Pathway.
    Guo ZL; Li Y; Liu XW; Wu MY; Guo Q; Yao XC; Wang YD; Wu WY
    Curr Eye Res; 2020 Feb; 45(2):177-183. PubMed ID: 31576759
    [No Abstract]   [Full Text] [Related]  

  • 11. Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown.
    Kuo C; Green CR; Rupenthal ID; Mugisho OO
    Acta Diabetol; 2020 Jan; 57(1):13-22. PubMed ID: 31030263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
    Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction.
    Scuderi S; D'Amico AG; Castorina A; Imbesi R; Carnazza ML; D'Agata V
    Peptides; 2013 Jan; 39():119-24. PubMed ID: 23220033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage.
    D'Amico AG; Maugeri G; Rasà D; Federico C; Saccone S; Lazzara F; Fidilio A; Drago F; Bucolo C; D'Agata V
    J Cell Physiol; 2019 Apr; 234(4):5230-5240. PubMed ID: 30374973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
    Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
    FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
    Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
    Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
    Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
    Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
    [No Abstract]   [Full Text] [Related]  

  • 20. Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema.
    Beasley S; El-Sherbiny M; Megyerdi S; El-Shafey S; Choksi K; Kaddour-Djebbar I; Sheibani N; Hsu S; Al-Shabrawey M
    Biomed Res Int; 2014; 2014():417986. PubMed ID: 25121097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.